Tag: abbott

First patients enrolled in SUPERSURG study of Supera peripheral stent system

ID3 Medical Belgium has announced the first two enrolments in the SUPERSURG study to investigate the safety and efficacy of Abbott's Supera peripheral stent...

VIVA 2019: ABSORB BVS achieves “excellent” long-term patency and freedom from...

Ramon Varcoe today announced positive five-year results of the ABSORB BTK trial at the 2019 Vascular Interventional Advances conference (VIVA) in Las Vegas, USA...

InspireMD announces expansion of its distribution network for CGuard EPS in...

InspireMD has announced it has signed Diverse Devices as its exclusive distributor for Australia and New Zealand, and has signed Do Gia Production...

Terumo completes acquisition of vascular closure business and other assets of...

Terumo has announced that it has completed its acquisition of certain assets owned by Abbott and St Jude Medical on 20 January 2017 (North...

Abbott completes St Jude Medical acquisition

Abbott announced on 4 January 2017 that it has completed the acquisition of St Jude Medical. “Abbott has a strong track record of successfully integrating...

Terumo signs to acquire St Jude Medical and Abbott’s vascular closure...

Terumo has reached an agreement with Abbott and St Jude Medical to acquire certain products owned by both for a total of US$1.12 billion. Based...
Interventional News for specialists

St Jude Medical shareholders approve merger with Abbott

St Jude Medical has announced that, based on the preliminary voting results from St Jude Medical’s Annual Meeting of Shareholders held on 26 October,...

Terumo looks to buy vascular closure and electrophysiology businesses from St...

Abbott and St Jude Medical have announced an agreement in principle to sell certain products to Terumo Corporation.The agreement is an important step toward...